International Biotechnology Trust’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

International Biotechnology Trust’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-10,200	Closed	-$1.18M	–	60
2020 Q4	$1.18M	Hold	10,200	–	–	0.32%	39
2020 Q3	$993K	Hold	10,200	–	–	0.32%	44
2020 Q2	$1.24M	Hold	10,200	–	–	0.41%	37
2020 Q1	$893K	Hold	10,200	–	–	0.41%	37
2019 Q4	$1.07M	Sell	10,200 -9,600	-48%	-$1.08M	0.38%	46
2019 Q3	$2.28M	Buy	19,800 +8,800	+80%	+$1.34M	1.05%	22
2019 Q2	$1.9M	Sell	11,000 -5,800	-35%	-$1M	0.7%	37
2019 Q1	$2.83M	Buy	16,800 +7,200	+75%	+$1.07M	1.05%	33
2018 Q4	$732K	Hold	9,600	–	–	0.45%	37
2018 Q3	$1.27M	Hold	9,600	–	–	0.6%	38
2018 Q2	$1.34M	Hold	9,600	–	–	0.51%	41
2018 Q1	$1.08M	Hold	9,600	–	–	0.42%	50
2017 Q4	$1.27M	Buy	+9,600	New	+$1.13M	0.45%	47
2017 Q3	–	Sell	-9,200	Closed	-$922K	–	69
2017 Q2	$922K	Hold	9,200	–	–	0.35%	52
2017 Q1	$1.11M	Buy	9,200 +1,700	+23%	+$209K	0.43%	46
2016 Q4	$838K	Buy	+7,500	New	+$903K	0.38%	40

Other funds holding GWPH

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

International Biotechnology Trust's GWPH Position: Q1 2021 in Review

International Biotechnology Trust sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2021, closing a stake of 10,200 shares — an estimated $1.18M sold.

International Biotechnology Trust first reported a position in GWPH in Q4 2016 and held it in 16 quarters. The position peaked at $2.83M in Q1 2019. 297 funds tracked by Wall St. Rank hold GWPH as of Q1 2021.

International Biotechnology Trust reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2021 after selling out during the quarter.
International Biotechnology Trust sold 10,200 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2021, an estimated $1.18M.
International Biotechnology Trust first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2016 and held it in 16 quarters.
International Biotechnology Trust's GW Pharmaceuticals Plc American Depositary Shares position peaked at $2.83M in Q1 2019.
297 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2021.

Based on International Biotechnology Trust's 13F filing for Q1 2021, filed 17 May 2021.